These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


435 related items for PubMed ID: 1640953

  • 1. Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group.
    Ponticelli C, Zucchelli P, Passerini P, Cesana B.
    N Engl J Med; 1992 Aug 27; 327(9):599-603. PubMed ID: 1640953
    [Abstract] [Full Text] [Related]

  • 2. A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy.
    Ponticelli C, Zucchelli P, Passerini P, Cagnoli L, Cesana B, Pozzi C, Pasquali S, Imbasciati E, Grassi C, Redaelli B.
    N Engl J Med; 1989 Jan 05; 320(1):8-13. PubMed ID: 2642605
    [Abstract] [Full Text] [Related]

  • 3. A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy.
    Ponticelli C, Passerini P, Salvadori M, Manno C, Viola BF, Pasquali S, Mandolfo S, Messa P.
    Am J Kidney Dis; 2006 Feb 05; 47(2):233-40. PubMed ID: 16431252
    [Abstract] [Full Text] [Related]

  • 4. Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy.
    Ponticelli C, Zucchelli P, Imbasciati E, Cagnoli L, Pozzi C, Passerini P, Grassi C, Limido D, Pasquali S, Volpini T.
    N Engl J Med; 1984 Apr 12; 310(15):946-50. PubMed ID: 6366560
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Controlled trial of monthly alternated courses of steroid and chlorambucil for idiopathic membranous nephropathy.
    Ponticelli C, Zucchelli P, Imbasciati E, Cagnoli L, Pozzi C, Grassi C, Limido D, Pasquali S, Passerini P, Volpini T, Locatelli F.
    Proc Eur Dial Transplant Assoc; 1983 Apr 12; 19():717-23. PubMed ID: 6348763
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.
    Goumenos DS, Katopodis KP, Passadakis P, Vardaki E, Liakopoulos V, Dafnis E, Stefanidis I, Vargemezis V, Vlachojannis JG, Siamopoulos KC.
    Am J Nephrol; 2007 Apr 12; 27(3):226-31. PubMed ID: 17389782
    [Abstract] [Full Text] [Related]

  • 12. Complete remission of nephrotic syndrome after steroid-chlorambucil in a previous failed short-term steroidal treatment of a primary membranous nephropathy.
    Ardiles LG, Mezzano SA.
    Clin Nephrol; 1996 Jun 12; 45(6):423. PubMed ID: 8793243
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Idiopathic membranous nephropathy in the elderly.
    Passerini P, Como G, Viganò E, Melis P, Pozzi C, Altieri P, Ponticelli C.
    Nephrol Dial Transplant; 1993 Jun 12; 8(12):1321-5. PubMed ID: 8159299
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Idiopathic membranous nephropathy and nephrotic syndrome: outcome in the era of evidence-based therapy.
    McQuarrie EP, Stirling CM, Geddes CC.
    Nephrol Dial Transplant; 2012 Jan 12; 27(1):235-42. PubMed ID: 21558430
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.